Sangui Biotech International (HAM:SBH) EV-to-Revenue : 14.99 (As of May. 24, 2024)

Sangui Biotech International EV-to-Revenue Chart

Sangui Biotech International Annual Data
	Trend	Jun13	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22
EV-to-Revenue		Get a 7-Day Free Trial					44.66	20.48	102.40	71.37	32.44

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-Revenue	Get a 7-Day Free Trial															56.00	32.44	27.36	13.48	13.87

Competitive Comparison of Sangui Biotech International's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangui Biotech International's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's EV-to-Revenue falls into.

Sangui Biotech International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sangui Biotech International's EV-to-Revenue for today is calculated as:

Sangui Biotech International's current Enterprise Value is €1.18 Mil.
Sangui Biotech International's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangui Biotech International  (HAM:SBH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sangui Biotech International's PS Ratiofor today is calculated as:

Sangui Biotech International's share price for today is €0.002.
Sangui Biotech International's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangui Biotech International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (HAM:SBH) Business Description